King Saud University
  Help (new window)

تحميل الدليل التدريبي

أسئلة شائعة



1-     SHIBL A.M, Antibiotic susceptibility and serotype prevalence of S. Pneumonia in children under 5 years old, Saudi Arabia,

     Vaccine 2007 (In press).

2-     Memish, Z.  Ahme Q, SHIBL A.M and Neidermann M.  Guidelines for Hospital acquire Pneumoniae in the Gulf region, J Chemotherapy 2007 (accepted for publication).  

3-     Hausdorff WP, Hajjeh R. Al-Mazrou, SHIBL A.M, Soriano-Gabarro M: Middle East & North Africa Vaccine-Preventable Diseases   

      Regional Advisory Group – The epidemiology of pneumococcal, meningococcal, and Haemophilus disease     

      in the Middle East and   North Africa (MENA) region-current status and needs. Vaccine. 2007 Mar 1;25(11):       


      4-  Balkhy HM, Memish ZA, SHIBL A.M., Elbashier A, Osoba A. In vitro activity of quinolones against S.       

            pneumoniae, H. influenzae and  M. catarrhalis in Saudi Arabia. East Mediterr Health J. 2005 Jan-Mar; 11(1-           

           2); 36-44.

       5   SHIBL A.M. Pattern of macrolide resistance determinants among S. pyogenes and S. pneumoniae         

      isolates in Saudi Arabia. J. Int.     Med Res. 2005 May-Jun; 33(3): 349-55.

6-      Fouda SI, Kadry AA, SHIBL A.M.. ß-lactam and macrolide resistance and serotype distribution among               

      Streptococcus pneumoniae isolates from Saudi Arabia. J Chemother. 2004 Dec; 16(6): 517-23.

7-     Song JH, Jung SI, Ko KS, Kim NY, Son JS, Chang HH, Ki HK, Oh WS, Suh JY, Peck KR, Lee NY, Yang Y, Lu Q, Chongthaleong A,     Chiu CH, Lalitha MK, Perera J, Yee TT, Kumarasinghe G, Jamal F, Kamarulzaman A, Parasakthi N, Van PH, Carlos C, So T, NG SHIBL A.M.  High prevalence of antimicrobial resistance among clinical Streptococcus pneumoniae isolates in Asia (an      

     ANSORP study). Antimicrob Agents Chemother. 2004 Jun; 48(6): 2101-7.  

8-     Memish ZA, Balkhy HH, SHIBL A.M., Barrozo CP, Gray GC. Streptococcus pneumoniae in Saudi Arabia: antibiotic              

      resistance and serotypes of recent clinical isolates.  Int. J. Antimicrob. Agents. 2004 Jan:23(1): 32-8.


9-      Shibl A.M., Al Rasheed AM. Elbashier AM. Osoba AO. Penicillin-resistant and –intermediate Streptococcus pneumoniae in Saudi      

       Arabia. Journal of Chemotherapy. 12(2): 134-7, 2000.

       11-  Abu el-Asrar AM. Kadry AA. Shibl A.M.. Al-Kharashi SA. Al-Mosallam AA. Antibiotics in the irrigating solutions reduce

             Staphylococcus epidermidis adherence to intraocular lenses. Eye 14  (Pt 2): 225-30, 2000.

      12- Kadry AA. Tawfik A. Abu El-Asrar AA. Shibl A.M.. Reduction of mucoid Staphylococcus epidermidis adherence to intraocular  

              lenses by selected antimicrobial agents. Chemotherapy. 45(1): 56-60, 1999.

13-     Shibl A.M. Memish Z. Abdulla A. Mian MY. Incidence of beta-lactamase production by oral aerobic/anaerobic flora from patients  

         admitted for elective tonsillectomy. Journal of Infection. 36(3): 355-6, 1998.

14-    Kessie G. Ettayebi M. Haddad AM. Shibl A.M. Al-Ahammary FJ. Tawfik AF. Al-Ahdal MN. Plasmid profile and antibiotic resistance  

       in coagulase-negative staphylococci isolated from polluted warer. Journal of Applied Microbiology. 84(3): 417-22, 1998.

15-    Shibl A.M. Antibacterial activity of Loracarbef compared with other commonly used oral antibiotics against community acquired  

       pathogens. Current Therapeutic Research. 1997, 58, 71.

16-    Abu el-Asrar AM. Shibl A.M. AM. Tabbara KF. Al-Kharashi SA. Heparin and heparin-surface-modification reduce Staphylococcus

        epidermidis adhesion to intraocular lenses. International Ophthalmology. 21(2): 71-4, 1997.

17-    Tawfik AF. Ramadan MA. Shibl A.M. Inhibition of motility and adherence of Proteus mirabilis to uroepithelial cells by subinhibitory

        concentrations of amikacin Chemotherapy. 43(6): 424-9, 1997.

18-    F.A. Al-Zamel, A.F. Tawfik, F.J. Al-Shammary, T.A. El-Kersh, A.M. Kambal and Shibl A.M. Antibiotic resistance and serotypes of clinical  

        isolates of P. aeruginosa in Riyadh. IRCS Medical Science Research, 1996, 24, 103.

19-    Fayed DF. Dahmash NS. Al-Zeer AH. Shibl A.M. Huraib SO. Abu-Aisha H. Efficacy and safety of once-daily amikacin in combination

        with ceftazidime in critically ill adults with severe gram-negative infections. Journal of Chemotherapy. 8(6): 457-64, 1996.

20-    Tawfik AF. Al-Zamil FA. Ramadan MA. Shibl A.M. Effect of beta-lactamase inhibitors on normal immune capabilities and their interactions with Staphylococcal pathogenicity.  Journal of Chemotherapy. 8(2): 102-6, 1996.

21-    Al-Meshal MA. Ramadan MA. Lotfi KM. Shibl A.M. Determination of meropenem in plasma by high-performance liquid chromatography

        and a microbiological method. Journal of Clinical Pharmacy & Therapeutics. 20(3): 159-63, 1995.

22-    Ramadan MA. Tawfik AF. Shibl A.M. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae,

        Serratia marcescens and Pseudomonas aeruginosa of beta-lactam   antibiotics. Chemotherapy. 41(3): 193-9, 1995.

23-    Shibl A.M. Pechere JC. Ramadan MA. Postantibiotic effect and host-bacteria interactions. Journal of Antimicrobial Chemotherapy.  

               36(6): 885-7, 1995.

24-    El-Karsh T. Tawfik AF. Al-Shammary F. Al-Salah S. Kambal AM. Shibl A.M. Antimicrobial resistance and prevalence of extended spectrum beta-lactamase among clinical isolates of gram-negative bacteria in Riyadh. Journal of Chemotherapy. 7(6): 509-14, 1995.

25-    Ramadan MA. Tawfik AF. Shibl A.M. Gemmell CG. Post-antibiotic effect of azithromycin and erythromycin on streptococcal susceptibility to phagocytosis. Journal of Medical Microbiology. 42(5): 362-6, 1995.

26-    Ramadan MA. Tawfik AF. El-Kersh TA. Shibl A.M. In vitro activity of subinhibitory concentrations of quinolones on urea-splitting bacteria:effect on urease activity and on cell surface hydrophobicity. Journal of Infectious Diseases. 171(2): 483-6, 1995.

27-    Shibl A.M. Antibacterial activity of Ampicillin alone and in combination with sulbatam: Correlation with B-lactamase production. Current Therapuetic Research, 1994, 55, 1304.

28-    A.F. Tawfik, Shibl A.M. M.O. Khalid and M.A. Ramadan. In-vitro antibacterial activity of fluoroquinolones against Enterobacteriaceae, Pseudomonas and Staphylococci isolated from Riyadh hospitals. Saudi Pharmaceutical Journal, 1994, 2, 169.

29-    Shibl A.M. Trends in microbial resistance to antibiotics. Saudi Pharmaceutical Journal, 1994, 4, 183.

30-    Shibl A.M. Ramadan MA. Tawfik AK. Post antibiotic effect of roxithromycin on streptolysin O production, hydrophobicity, and bactericidal activity of PMNL by Streptococcus pyogenes. Diagnostic Microbiology & Infectious Disease. 20(1): 7-11, 1994.

31-    Shibl A.M. Gaillot O. Susceptibility of clinically significant Haemophilias Influenza strains to oral anti-microbial agents used in Saudi Arabia. Chemotherapy. 40(6): 399-403, 1994.

32-    Shibl A.M. Tawfik AF. Khan AM. Qadri SM. Imambaccus Y. Ramadan MA. Prevalence of methicillin-resistant staphylococci in Riyadh, Saudi Arabia and their susceptibility to antimicrobial agents. Journal of Antimicrobial Chemotherapy. 33(6): 1255-7, 1994.

33-    Shibl A.M. Ramadan MA. Tawfik AF. Differential inhibition by clindamycin on slime formation, adherence to Teflon catheters and hemolysin production by Staphylococcus epidermidis. Journal of Chemotherapy. 6(2): 107-10, 1999

34-    Shibl A.M. A.F. Tawfik A.M. Khan, S.M. Hussein Qadri and M. Ramadan. Prevalence of methicillin-resistant Staphylococci and

               susceptibility to antimicrobial agents in Riyadh, Saudi Arabia.  Current Therapeutic Research, 1994, 55,         


35-    Shibl A.M. In-vitro antimicrobial susceptibility data, is it necessary for making formulary decisions.  Saudi Medical Journal 1994, 15(4), 326.

36-    Al-Dhohayan A. al-Sebayl M. Shibl A.M. al-Eshalwy S. Kattan K. al-Saleh M. Comparative study of augmentin versus metronidazole/gentamicin in the prevention of infections after appendicectomy.  European Surgical Research. 25(1): 60-4, 1993.

37-    Moneib NA. Shibl A.M. El-Said MA. El-Masry EM. Macrolides induced suppression of virulence factors produced by Staphylococcus aureus. Journal of Chemotherapy. 5(5): 289-92, 1993.

38-    Shibl A.M. Incidence of beta-lactamase production among out patient clinical isolates in Middle Eastern countries and their antibiotic susceptibioities.  Middle Eastern Study Group. Chemotherapy. 38(5): 324-9, 1992.

39-    Moneib NA. El-Said MA. Shibl A.M. Correlation between the in-vivo and in vitro antimicrobial properties of commercially available mouthwash preparations. Journal of Chemotherapy. 4(5): 276-80, 1992.

40-    Shibl A.M. Hussein SS. Surveillance of Streptococcus pneumoniae serotypes in Riyadh and their susceptibility to penicillin and other commonly prescribed antibiotics.  Journal of Antimicrobial Chemotherapy. 29(2): 149-57, 1992.

41-    Fayed DF. Dahmash NS. Saddiqque AA. Shibl A.M. Evaluation of aztreonam in the treatment of serious gram-negative infections in a university hospital in Saudi Arabia. Journal of Chemotherapy. 4(3): 167-70, 1992.

42-    F. Al-Zamil, Shibl A.M. S.M.H. Qadri. Detection of pneumococcal with increased resistance to penicillin and their clinical significance.  Annals of Saudi Medicine. 1992, 12, 279.

43-    Shibl A.M.. The in-vitro activity of Aztreonam against local colonical isolates in Saudi Arabia.  Current Therapeutic Research 1992, 52, 106.

44-    Shibl A.M. Tawfik AF. El-Houfy S. al-Shammary FJ. Determination of lomefloxacin in biological fluids by high-performance liquid chromatography and a microbiological method.  Journal of Clinical Pharmacy & Therapeutics. 16(5): 353-9, 1991.


King   Saud University. All rights reserved, 2007 | Disclaimer | CiteSeerx